Silvia Guzmán Vázquez
YOU?
Author Swipe
View article: Generation of human induced pluripotent stem cell lines from two down syndrome patients, including a down syndrome/Alzheimer’s disease case (FLENIi002-A) and a beta-amyloid-resistant case (FLENIi003-A)
Generation of human induced pluripotent stem cell lines from two down syndrome patients, including a down syndrome/Alzheimer’s disease case (FLENIi002-A) and a beta-amyloid-resistant case (FLENIi003-A) Open
View article: Evaluation of a risk-sharing agreement for atezolizumab treatment in patients with non-small cell lung cancer: a strategy to improve access in low-income countries
Evaluation of a risk-sharing agreement for atezolizumab treatment in patients with non-small cell lung cancer: a strategy to improve access in low-income countries Open
Background Using immune checkpoint inhibitors (IO) is a promising approach to maximize clinical benefits for patients with non-small cell lung cancer (NSCLC). PD-L1 expression serves as a predictive factor for treatment outcomes with IO. H…
View article: Breast Cancer Patient’s Outcomes after Neoadjuvant Chemotherapy and Surgery at 5 and 10 Years for Stage II–III Disease
Breast Cancer Patient’s Outcomes after Neoadjuvant Chemotherapy and Surgery at 5 and 10 Years for Stage II–III Disease Open
Introduction: Neoadjuvant chemotherapy in breast cancer offers the possibility to facilitate breast and axillary surgery; it is a test of chemosensibility in vivo with significant prognostic value and may be used to tailor adjuvant treatme…
View article: Patient Outcomes at 5 and 10 Years After Neoadjuvant Chemotherapy for Stage II and III Breast Cancer
Patient Outcomes at 5 and 10 Years After Neoadjuvant Chemotherapy for Stage II and III Breast Cancer Open
Introduction: Neoadjuvant chemotherapy in breast cancer offers the possibility to facilitate breast and axillary surgery, it is a test of chemosensibility in vivo with significant prognostic value and may tailor adjuvant treatment accordin…
View article: Hereditary angioedema: Patient journey approach in Mexico.
Hereditary angioedema: Patient journey approach in Mexico. Open
Objective: To understand the patient’s journey with HAE from symptom initiation to diagnosis, treatment allocation, follow-up, and the impact of the disease on their quality of life in Mexico. Methods: A survey was administered to the pati…
View article: Esclerectomía profunda no perforante (EPNP) en Glaucoma primario de ángulo abierto (GPAA)
Esclerectomía profunda no perforante (EPNP) en Glaucoma primario de ángulo abierto (GPAA) Open
Glaucoma is a multifactorial optic neuropathy whose main risk factor is the increase in intraocular pressure (IOP) that leads to a progressive worsening of the optic nerve, which in turn entails a characteristic alteration of the head of t…
View article: Efficacy, Safety, and Cost-Minimization Analysis of Continuous Infusion of Low-Dose Gemcitabine Plus Cisplatin in Patients With Unresectable Malignant Pleural Mesothelioma
Efficacy, Safety, and Cost-Minimization Analysis of Continuous Infusion of Low-Dose Gemcitabine Plus Cisplatin in Patients With Unresectable Malignant Pleural Mesothelioma Open
Background Malignant pleural mesothelioma (MPM) is rare and aggressive neoplasia, with a poor prognosis; furthermore, the monetary cost of its treatment represents a major challenge for many patients. The economic burden this malignancy im…
View article: Role of disease-modifying oral drugs in multiple sclerosis: A systematic review with meta-analysis
Role of disease-modifying oral drugs in multiple sclerosis: A systematic review with meta-analysis Open
The purpose of the study was to evaluate the efficacy and safety of cladribine tablets compared with all oral therapies used in patients with relapsing-remitting multiple sclerosis (RRMS).A systematic review of the literature was conducted…
View article: Cost-effectiveness analysis of first and second-generation EGFR tyrosine kinase inhibitors as first line of treatment for patients with NSCLC harboring EGFR mutations
Cost-effectiveness analysis of first and second-generation EGFR tyrosine kinase inhibitors as first line of treatment for patients with NSCLC harboring EGFR mutations Open
View article: P2‐320: ARGENTINIAN INITIATIVE FOR THE STUDY OF DOWN SYNDROME AND ALZHEIMER'S DISEASE (IASDA)
P2‐320: ARGENTINIAN INITIATIVE FOR THE STUDY OF DOWN SYNDROME AND ALZHEIMER'S DISEASE (IASDA) Open
Alzheimer's Disease (AD) is not only more frequent and has an earlier onset in Down Syndrome (DS) than in the general population, but also has an atypical clinical phenotype and an uncertain genetic risk factor and biomarker profile. The a…
View article: A biological classification for Alzheimer’s disease - Amyloid, Tau and Neurodegeneration (A/T/N): results from the Argentine-Alzheimer’s Disease Neuroimaging Initiative
A biological classification for Alzheimer’s disease - Amyloid, Tau and Neurodegeneration (A/T/N): results from the Argentine-Alzheimer’s Disease Neuroimaging Initiative Open
An abstract is not available for this content. As you have access to this content, full HTML content is provided on this page. A PDF of this content is also available in through the 'Save PDF' action button.
View article: Cost-Effectiveness of Azacitidine Compared with Low-Doses of Chemotherapy (LDC) in Myelodysplastic Syndrome (MDS)
Cost-Effectiveness of Azacitidine Compared with Low-Doses of Chemotherapy (LDC) in Myelodysplastic Syndrome (MDS) Open
Introduction Myelodysplastic syndrome (MDS) comprises a group of clonal hematological disorders, characterized by ineffective hematopoiesis and progressive bone marrow failure. It increases the risk of transformation to acute myeloid leuke…
View article: Cost-Effectiveness of Azacitidine Compared with Low-Doses of Chemotherapy (LDC) in Myelodysplastic Syndrome (MDS)
Cost-Effectiveness of Azacitidine Compared with Low-Doses of Chemotherapy (LDC) in Myelodysplastic Syndrome (MDS) Open
IntroductionMyelodysplastic syndrome (MDS) comprises a group of clonal hematological disorders, characterized by ineffective hematopoiesis and progressive bone marrow failure. It increases the risk of transformation to acute myeloid leukem…
View article: Safety-and-efficacy-of-portable-nebulizer-NE-C801KD-for-humid-application-on-paediatric-patients-with-non-complicated-upper-respiratory-tract-viral-infections.-Pilot-study
Safety-and-efficacy-of-portable-nebulizer-NE-C801KD-for-humid-application-on-paediatric-patients-with-non-complicated-upper-respiratory-tract-viral-infections.-Pilot-study Open